Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines.

BACKGROUND Hypertriglyceridemia (HTG) is a heterogeneous metabolic disorder. The aim of this study was to examine associations among genetic polymorphisms, SstI polymorphism of apolipoprotein CIII (ApoCIII) and Hind III polymorphism of lipoprotein lipase (LPL), environmental factors and risks of HTG. METHODS AND RESULTS Two hundred and forty-nine southern Taiwanese aborigines were recruited for a cross-sectional study, which included 90 subjects with triglyceride (TG)>150 mg/dl (HTG) and 159 with TG<or=150 mg/dl (NTG). The frequencies of SstI major allele (S1) and minor allele (S2) of ApoCIII were 66.1% and 33.9% in HTG and 73.6% and 26.4% in NTG (p<0.1). In female subjects, the frequencies of the S2 allele was significantly higher in HTG (0.38) than NTG (0.27) (p<0.04). The frequencies of the LPL HindIII major allele (H+) and minor allele (H-) were similar between HTG (H+ 84.3%; H- 15.7%) and NTG (H+ 78.9%; H- 21.1%). In a multivariate adjusted logistic model, education<or=6 year (odds ratio (OR)=3.71, 95% confidence interval (CI): 1.24-8.13), Amis tribe (OR=3.08, 95% CI: 1.41-6.77), body mass index (BMI)>or=25 (OR=2.22, 95% CI: 1.18-4.16), starchy food consumption>or=3 times/week (OR=1.89, 95% CI: 1.00-3.59) and ApoCIII S2S2 genotype (OR=3.35, 95% CI: 1.10-10.19) were independently (p<0.05) associated with HTG risks. Among ApoCIII S1S1, S1S2 and S2S2 genotypes, ApoCIII and TG concentrations increased (p<0.01) in a dose-responsive manner. CONCLUSIONS The ApoCIII S2 variant and environmental factors, including education, tribal background, BMI and starchy food intake, modulate the risks of HTG in aboriginal Taiwanese. Interaction between genetic and environmental factors warrants further investigation.

[1]  A. Hedley,et al.  Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. , 2004, Obesity research.

[2]  S. Kihara,et al.  Adiponectin as a biomarker of the metabolic syndrome. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[3]  M. Fujita,et al.  Low Serum α-Tocopherol Concentrations in Subjects With Various Coronary Risk Factors , 2004 .

[4]  S. Fried,et al.  Sugars, hypertriglyceridemia, and cardiovascular disease. , 2003, The American journal of clinical nutrition.

[5]  P. Stiefel,et al.  Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients. Interaction between gender and genetic polymorphism. , 2003, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[6]  R. Narang,et al.  Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians , 2002, BMC Genetics.

[7]  D. Corella,et al.  Associations of LPL and APOC3 gene polymorphisms on plasma lipids in a Mediterranean population: interaction with tobacco smoking and the APOE locus. , 2002, Journal of lipid research.

[8]  P. Wilson,et al.  Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. , 2001, Atherosclerosis.

[9]  R. Hamman,et al.  Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels , 2000, Human Genetics.

[10]  P. Amouyel,et al.  Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France. , 2000, Atherosclerosis.

[11]  J. Kao,et al.  DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: correlation of plasma APOCIII with triglyceride level and body mass index. , 2000, Journal of the Formosan Medical Association = Taiwan yi zhi.

[12]  J. Ribalta,et al.  ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests. , 1999, Circulation.

[13]  J. Carlquist,et al.  Association of lipoprotein lipase gene polymorphisms with coronary artery disease. , 1999, Journal of the American College of Cardiology.

[14]  J. Ordovás,et al.  Genes, variation of cholesterol and fat intake and serum lipids. , 1999, Current opinion in lipidology.

[15]  J. Ordovás,et al.  The SstI polymorphism of the apolipoprotein C-III gene determines the insulin response to an oral-glucose-tolerance test after consumption of a diet rich in saturated fats. , 1998, The American journal of clinical nutrition.

[16]  P. Talmud,et al.  Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[17]  J. Hokanson,et al.  Hypertriglyceridemia as a cardiovascular risk factor. , 1998, The American journal of cardiology.

[18]  G. Assmann,et al.  The Münster Heart Study (PROCAM). Results of follow-up at 8 years. , 1998, European heart journal.

[19]  Y. Ko,et al.  Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese , 1997, Human Genetics.

[20]  J. Rotter,et al.  Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes. , 1997, The Journal of clinical investigation.

[21]  N. Cox,et al.  Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children , 1996, Human Genetics.

[22]  J. Breslow Mouse Models of Atherosclerosis , 1996, Science.

[23]  M. Hayden,et al.  Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects. , 1996, Journal of lipid research.

[24]  J. Breslow,et al.  Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. , 1995, The Journal of clinical investigation.

[25]  M. Stoneking,et al.  Polynesian genetic affinities with Southeast Asian populations as identified by mtDNA analysis. , 1995, American journal of human genetics.

[26]  R. Winter,et al.  Previously apparently undescribed syndrome: shallow orbits, ptosis, coloboma, trigonocephaly, gyral malformations, and mental and growth retardation. , 1995, American journal of medical genetics.

[27]  J. Sasaki,et al.  An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population , 1995, Human Genetics.

[28]  Y. Ko,et al.  [Issues on aboriginal health in Taiwan]. , 1994, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences.

[29]  A. Deev,et al.  The association of education with coronary heart disease mortality in the USSR Lipid Research Clinics Study. , 1993, International journal of epidemiology.

[30]  J. Breslow,et al.  An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Humphries,et al.  Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. , 1993, Atherosclerosis.

[32]  S. Humphries,et al.  Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. , 1992, Atherosclerosis.

[33]  P. Bellwood,et al.  The Austronesian Dispersal and the Origin of Languages , 1991 .

[34]  C. Shoulders,et al.  Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII. , 1991, Atherosclerosis.

[35]  K. Johansen,et al.  Coronary artery disease and apolipoprotein A‐I/C‐III gene polymorphism: a study of Saudi Arabians , 1991, Clinical genetics.

[36]  D. Galton,et al.  DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. , 1989, Atherosclerosis.

[37]  P. Wenham,et al.  DNA RESTRICTION FRAGMENT LENGTH POLYMORPHISMS AS MARKERS OF FAMILIAL CORONARY HEART DISEASE , 1989, The Lancet.

[38]  D. Galton,et al.  A DNA polymorphism of the apolipoprotein C-III gene in extracoronary atherosclerosis. , 1988, Clinical science.

[39]  T. Mohandas,et al.  Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. , 1987, Genomics.

[40]  C. Vergani,et al.  Restriction-fragment-length polymorphisms in the A-I-C-III gene complex occurring in a family with hypoalphalipoproteinemia. , 1986, Atherosclerosis.

[41]  D. Galton,et al.  haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia , 1986, Human Genetics.

[42]  A. Camm,et al.  DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis. , 1985, Atherosclerosis.

[43]  S. Karathanasis Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[44]  D. Galton,et al.  GENETIC POLYMORPHISMS OF APOLIPOPROTEIN C-III AND INSULIN IN SURVIVORS OF MYOCARDIAL INFARCTION , 1985, The Lancet.

[45]  C. S. Wang,et al.  Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. , 1985, The Journal of clinical investigation.

[46]  B. Kamel,et al.  Food habits and nutrient intake of Kuwaiti males and females , 1984 .

[47]  G. Bruns,et al.  Human Apolipoprotein A‐I‐C‐III Gene Complex is Located on Chromosome II , 1984, Arteriosclerosis.

[48]  C. Shoulders,et al.  DNA POLYMORPHISM ADJACENT TO HUMAN APOPROTEIN A-1 GENE: RELATION TO HYPERTRIGLYCERIDAEMIA , 1983, The Lancet.

[49]  G. Schonfeld,et al.  Apolipoprotein C-II and C-III levels in hyperlipoproteinemia. , 1979, Metabolism: clinical and experimental.

[50]  S. Livingston,et al.  ONE-DRUG REGIMENS FOR EPILEPSY , 1976, The Lancet.

[51]  H. Yatsuya,et al.  Long-term body weight fluctuation is associated with metabolic syndrome independent of current body mass index among Japanese men. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[52]  M. Fujita,et al.  Low serum alpha-tocopherol concentrations in subjects with various coronary risk factors. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[53]  K. Arakawa,et al.  Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population , 2004, Human Genetics.

[54]  Jin Q. Kim,et al.  Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. , 1997, Clinical chemistry.

[55]  J. Rotter,et al.  Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: effects on LDL-cholesterol and apolipoproteins B and C-III. , 1996, Journal of lipid research.

[56]  Robert Blust,et al.  The Austronesian Homeland: A Linguistic Perspective , 1985 .

[57]  A. Shaw Letter: Another blood product. , 1974, Lancet.